XTENDI

xtendi-logo

Xtendi is developing an online studio for creating Augmented Reality experiences to design digital layers on physical objects using a simple โ€˜drag & dropโ€™ interface. Xtendi's studio offers a unique (patent pending) proximity feature that adds a new level of exploration. Users can interact with objects in their surroundings based on their natural human behavior. Just as in the real world when something interests you, you get closer to it to learn more about it, or sometimes you take a step back to see the wider context, Xtendi is mimicking this natural human behavior through AR technology. Xtendi believes that the potential of the technology resides in the USER, thatโ€™s why its focus is on the USER INTERACTION aspect of technology.

#SimilarOrganizations #People #Website #More

XTENDI

Social Links:

Industry:
Augmented Reality SaaS Software

Founded:
2012-03-01

Address:
Tel Aviv, Tel Aviv, Israel

Country:
Israel

Website Url:
http://www.xtendi.com

Total Employee:
1+

Status:
Active

Contact:
972544545254

Email Addresses:
[email protected]

Technology used in webpage:
Amazon Amazon Virginia Region Amazon S3 CDN Amazon Elastic Load Balancing Amazon ELB North Virginia


Similar Organizations

birdone-llc-logo

BirdOne LLC

Drone Augmented Reality SaaS Company

not_available_image

Cirqus

Events & Entertainment SaaS platform

mondodx-logo

MondoDX

Industrial Augmented Reality, SaaS

quark-experiences-pvt-ltd-logo

Quark Experiences Pvt. Ltd.

virtual Reality, 360, SaaS platform for VR

scapic-logo

Scapic

Virtual/Augmented Reality Start Up .

Current Employees Featured

not_available_image

Avinoam Shafran
Avinoam Shafran Co-Founder & VP Marketing @ Xtendi
Co-Founder & VP Marketing
2012-03-01

not_available_image

Ronny van den Bergh
Ronny van den Bergh Co-Founder & VP Product @ Xtendi
Co-Founder & VP Product
2012-03-01

Founder


not_available_image

Avinoam Shafran

not_available_image

Ronny van den Bergh

Official Site Inspections

http://www.xtendi.com

  • Host name: ec2-3-225-210-159.compute-1.amazonaws.com
  • IP address: 3.225.210.159
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Xtendi"

XTANDI Support Solutions® Welcome | XTANDI® (enzalutamide)

Jan 10, 2017 XTANDI Support Solutions, a component of Astellas Pharma Support Solutions SM, offers access and reimbursement support to help patients overcome challenges to โ€ฆSee details»

Prostate Cancer Support Organizations | XTANDI® (enzalutamide) โ€ฆ

XTANDI® (enzalutamide) is indicated for the treatment of patients with: nonmetastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis โ€ฆSee details»

Patient Assistance | XTANDI® (enzalutamide) tablets

Jan 10, 2017 The XTANDI Patient Savings Program b is for eligible patients with commercial prescription insurance. The Astellas Patient Assistance Program b provides XTANDI ® โ€ฆSee details»

Astellas Patient Assistance Program - Astellas Pharma Support โ€ฆ

Jan 10, 2017 The Astellas Patient Assistance Program a provides XTANDI ® (enzalutamide) at no cost to patients who meet the program eligibility requirements.See details»

XTANDI® (enzalutamide) Patient Support Solutions®

Learn about Support Solutions® for your patients prescribed XTANDI, a program that provides information on access and financial support for eligible patients.See details»

Astellas Xtandi Support Solutions

XTANDI Access allows you to enroll your patients in XTANDI Support Solutions online. XTANDI Support Solutions offers access and reimbursement support to help patients overcome โ€ฆSee details»

Contact us - XTANDI

Find contact information for Astellas Pharma US, Inc., Pfizer Inc., XTANDI Support Solutions®, and more.See details»

ASRS2314-00_XSS_AccessAfford_FS_Update_M

XTANDI Support Solutions offers access and reimbursement support to help patients and their healthcare providers access XTANDI® (enzalutamide). XTANDI Support Solutions provides โ€ฆSee details»

XTANDI® (enzalutamide) Receives Health Canada ... - Astellas โ€ฆ

XTANDI is a standard of care that has received regulatory approvals in more than 90 countries, including the United States, the European Union and Japan. In Canada, XTANDI is now โ€ฆSee details»

Patient Enrollment Process | XTANDI® (enzalutamide)

Jan 10, 2017 After your patient has been prescribed XTANDI ® (enzalutamide), enroll them in XTANDI Support Solutions a so they have access to financial assistance options and XTANDI โ€ฆSee details»

Enzalutamide - Wikipedia

Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen (NSAA) medication which is used in the treatment of prostate cancer. [2][9] It is indicated for use in conjunction with castration in the treatment of metastatic โ€ฆSee details»

Xtandi: Uses, Dosage & Side Effects - Drugs.com

Nov 21, 2023 Xtandi (enzalutamide) is an anti-androgen used to treat prostate prostate cancer. Includes Xtandi side effects, interactions and indications.See details»

XTANDI® Support Solutions Pamphlet

The XTANDI Patient Savings Program has a maximum copay assistance limit of $7,000 per calendar year. โ€  XTANDI Support Solutions has no control over the decisions made by and โ€ฆSee details»

XTANDI® (enzalutamide) | Advanced Prostate Cancer Treatment

XTANDI® is an androgen receptor inhibitor used for the treatment of 4 types of advanced prostate cancer. See Important Safety Info, Risks, & Benefits.See details»

Xtandi Approved for High-Risk Prostate Cancer - NCI

Jan 5, 2024 Enzalutamide (Xtandi) can now be used alone or combined with leuprolide to treat some people with prostate cancer who have had a biochemical recurrence.See details»

XTANDI Patient Savings Program - Astellas Pharma Support โ€ฆ

Jan 10, 2017 The XTANDI Patient Savings Program a is for eligible commercially insured patients taking XTANDI. The Program parameters are as follows:See details»

Health Canada Approves XTANDI® (enzalutamide), for the โ€ฆ

Jun 16, 2020 XTANDI® is the first and only androgen receptor-axis-targeted therapy (ARAT) approved by Health Canada in three clinical disease states of prostate cancer across four โ€ฆSee details»

word - OptumRx

Xtandi® (enzalutamide) โ€“ Expanded indication On November 17, 2023, Astellas and Pfizer announced the FDA approval of Xtandi (enzalutamide), for the treatment of patients with non โ€ฆSee details»

XTANDI Patient Connect - Astellas Pharma Support Solutions

Jan 10, 2017 XTANDI Support Solutions offers XTANDI Patient Connect to patients who have been prescribed XTANDI ® (enzalutamide). This additional support helps connect your patient โ€ฆSee details»

Xtandi Factsheet, Uses & Common Side Effects | Rexall

As Canada's trusted pharmacy, Rexall provides detailed drug factsheets for Xtandi with common uses, dosage instructions, side effects & drug interactions.See details»

linkstock.net © 2022. All rights reserved